Posts

President Biden forms "Cancer Moonshot" Program, Appoints Board Members   President Biden has signalled a new Federal commitment to oncology research by creating a "Cancer Moonshot" Program and Board.  This is a critical step in supporting not just basic research, but in applied oncology research. With CAR-T and other gene therapy approaches as well as other approaches now demonstrating clinical trial effectiveness, this is a propitious time to focus on cancer and oncology. https://www.fiercebiotech.com/biotech/moonshot-2-0-biden-wants-50-drop-cancer-death-rate-by-2047-establishes-cancer-cabinet
  AI being used to design proteins a new report from Science Daily confirms ever expanding use of AI in protein design,with big implications for drug design: https://www.sciencedaily.com/releases/2022/02/220201165655.htm
THE TOP TEN RNA-BASED BIOPHARMA COMPANIES According to a new report from Genetic Engineering & Biotechnology News ("GEN"), here they are: https://www.genengnews.com/topics/omics/top-10-rna-based-biopharmas-2/